Health
Rapid CD169 assay for COVID-19 screening – News-Medical.Net
Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory…
Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
The assay detects the upregulation of whole blood monocyte CD169, which has been reported as a marker of viral infections.
This rapid assay was more sensitive than the currently used method and less likely to produce false-negative results, especially among early and asymptomatic patients.
…
-
Noosa News19 hours agoQueensland GP accused of rape, sexual assault and torture pleads for bail despite ‘disturbing’ allegations
-
General19 hours agoDavid Littleproud’s own goal • Inside Story
-
General11 hours agoCoalition to chart path forward as family feud cooled
-
General22 hours agoDingo stabbed on K’gari (Fraser Island) after biting child